1. Home
  2. RBBN vs KMDA Comparison

RBBN vs KMDA Comparison

Compare RBBN & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$3.07

Market Cap

493.4M

Sector

Technology

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.73

Market Cap

460.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
KMDA
Founded
1997
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.4M
460.3M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
RBBN
KMDA
Price
$3.07
$7.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.67
$14.00
AVG Volume (30 Days)
1.0M
50.3K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
170.97
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.97
$13.94
Revenue Next Year
$6.69
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$6.50
52 Week High
$4.29
$9.35

Technical Indicators

Market Signals
Indicator
RBBN
KMDA
Relative Strength Index (RSI) 65.72 40.27
Support Level $2.72 $7.66
Resistance Level $3.09 $8.55
Average True Range (ATR) 0.17 0.19
MACD 0.04 -0.01
Stochastic Oscillator 75.60 34.10

Price Performance

Historical Comparison
RBBN
KMDA

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: